Synteni Overview
- Founded
-
1994
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$72.9M
Synteni General Information
Description
Developer of genomics microarrays technology. The company has developed Gene Expression Microarray (GEM) which consists of up to ten thousand genes densely arrayed on a glass surface. GEM arrays are capable of analyzing thousands of genes in a single experiment by probing with fluorescently tagged DNA or RNA from a biological sample.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- Palo Alto, CA 94306
- United States
Synteni Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 06-Jan-1998 | $72.9M | 000.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
Synteni Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Kleiner Perkins | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Shalon Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |